Aviad Tsherniak leads the Cancer Data Science group at the Broad Institute of MIT and Harvard. He is interested in developing computational methods enabling the identification of therapeutically relevant cancer vulnerabilities that would lead to new drug development efforts and a greater understanding of the biological mechanisms driving cancer.